BioVaxys Technology Corp says initial results from study int

BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) said interim results from its ongoing pre-clinical study shows its vaccine against a family of viruses...

Related Keywords

Ohio , United States , Ohio State University , Vancouver , British Columbia , Canada , David Berd , Kenneth Kovan , Biovaxys Technology Corp , Biovaxys Technology , Ohio State ,